Clusterin

Clusterin

Clusterin Molekülinformation

Molecule Name
Clusterin
Molekülalias
CLU,Clusterin,AAG4,APOJ,CLI,KUB1,SGP-2,SP-40,TRPM2
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
Epididymis Secretory Sperm Binding Protein,CLI,Apolipoprotein J,ApoJbeta,Complement cytolysis inhibitor a chain,Testosterone-repressed prostate message 2,Complement cytolysis inhibitor b chain,ApoJalpha,AAG4,Complement cytolysis inhibitor,NA1/NA2,APOJ,CLU,Clusterin,Complement-Associated Protein SP-40,40,Complement Lysis Inhibitor,Sulfated Glycoprotein 2,Ku70-Binding Protein 1,TRPM-2,KUB1,Clusterin (Complement Lysis Inhibitor, SP-40,40, Sulfated Glycoprotein 2, Testosterone-Repressed Prostate Message 2, Apolipoprotein J),Aging-Associated Gene 4 Protein,Aging-Associated Protein 4,APO-J,SGP-2,SP-40,CLU1,CLU2,SGP2,TRPM2
Molekülhintergrund
Clusterin (CLU) is also known as dimeric acidic glycoprotein (DAG protein), testosterone repressed prostate message-2 (TRPM-2), sulfated glycoprotein-2 (SGP-2) and complement lysis inhibitor (CLI), is a secreted multifunctional glycoprotein protein which belongs to the clusterin family. Intracellular cleavages of the precursor of clusterin remove the signal peptide and generate comparably sized α and β chains which are secreted as an 80 kDa N­glycosylated disulfide­linked heterodimer. DAG protein is predominantly expressed in adult testis, ovary, adrenal gland, liver, heart, and brain and in many epithelial tissues during embryonic development. Clusterin involve in several basic biological events such as cell death, tumor progression, and neurodegenerative disorders. Upregulation of clusterin mRNA and protein levels detected in diverse disease states and in in vitro systems have led to suggestions that it functions in membrane lipid recycling, in apoptotic cell death, and as a stress-induced secreted chaperone protein, amongst others.

Clusterin Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
SotevtamabAB-sCLU mAB; 16B5; AB-16B5Phase 2 ClinicalNational Research Council Biotechnology Research Institute
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasm Metastasis; Solid tumours
Details